MorphoSys AG
MorphoSys AG (MOR.SW) Stock Competitors & Peer Comparison
See (MOR.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MOR.SW | CHF 102.00 | +0.00% | 2.4B | -4.03 | -CHF 25.33 | N/A |
| GILD.SW | CHF 110.83 | -3.44% | 137.6B | 20.62 | CHF 5.38 | +2.30% |
| BION.SW | CHF 44.40 | -0.11% | 2.4B | 4.21 | CHF 10.54 | +5.07% |
| KURN.SW | CHF 23.24 | +4.40% | 910.5M | 387.33 | CHF 0.06 | N/A |
| IDIA.SW | CHF 3.61 | +4.03% | 720.5M | -6.94 | -CHF 0.52 | N/A |
| BSLN.SW | CHF 54.70 | +0.55% | 671.3M | 17.42 | CHF 3.14 | N/A |
| NWRN.SW | CHF 15.50 | +2.24% | 310.2M | -25.41 | -CHF 0.61 | N/A |
| SANN.SW | CHF 16.38 | +5.27% | 230.2M | -3.04 | -CHF 5.38 | N/A |
| MOLN.SW | CHF 3.05 | -2.24% | 114.1M | -1.85 | -CHF 1.65 | N/A |
| MMTX.SW | CHF 0.35 | +8.02% | 53.4M | N/A | N/A | N/A |
Stock Comparison
MOR.SW vs GILD.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, GILD.SW has a market cap of 137.6B. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while GILD.SW trades at CHF 110.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas GILD.SW's P/E ratio is 20.62. In terms of profitability, MOR.SW's ROE is -1.84%, compared to GILD.SW's ROE of +0.26%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and GILD.SW has daily volatility of 0.00.Check GILD.SW's competition here
MOR.SW vs BION.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, BION.SW has a market cap of 2.4B. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while BION.SW trades at CHF 44.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas BION.SW's P/E ratio is 4.21. In terms of profitability, MOR.SW's ROE is -1.84%, compared to BION.SW's ROE of -0.13%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and BION.SW has daily volatility of 2.12.Check BION.SW's competition here
MOR.SW vs KURN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, KURN.SW has a market cap of 910.5M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while KURN.SW trades at CHF 23.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas KURN.SW's P/E ratio is 387.33. In terms of profitability, MOR.SW's ROE is -1.84%, compared to KURN.SW's ROE of +0.02%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and KURN.SW has daily volatility of 3.19.Check KURN.SW's competition here
MOR.SW vs IDIA.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, IDIA.SW has a market cap of 720.5M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while IDIA.SW trades at CHF 3.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas IDIA.SW's P/E ratio is -6.94. In terms of profitability, MOR.SW's ROE is -1.84%, compared to IDIA.SW's ROE of +0.10%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and IDIA.SW has daily volatility of 6.40.Check IDIA.SW's competition here
MOR.SW vs BSLN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, BSLN.SW has a market cap of 671.3M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while BSLN.SW trades at CHF 54.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas BSLN.SW's P/E ratio is 17.42. In terms of profitability, MOR.SW's ROE is -1.84%, compared to BSLN.SW's ROE of +0.28%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and BSLN.SW has daily volatility of 1.81.Check BSLN.SW's competition here
MOR.SW vs NWRN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, NWRN.SW has a market cap of 310.2M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while NWRN.SW trades at CHF 15.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas NWRN.SW's P/E ratio is -25.41. In terms of profitability, MOR.SW's ROE is -1.84%, compared to NWRN.SW's ROE of +2.78%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and NWRN.SW has daily volatility of 4.35.Check NWRN.SW's competition here
MOR.SW vs SANN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, SANN.SW has a market cap of 230.2M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while SANN.SW trades at CHF 16.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas SANN.SW's P/E ratio is -3.04. In terms of profitability, MOR.SW's ROE is -1.84%, compared to SANN.SW's ROE of -5.22%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and SANN.SW has daily volatility of 3.73.Check SANN.SW's competition here
MOR.SW vs MOLN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, MOLN.SW has a market cap of 114.1M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while MOLN.SW trades at CHF 3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas MOLN.SW's P/E ratio is -1.85. In terms of profitability, MOR.SW's ROE is -1.84%, compared to MOLN.SW's ROE of -0.60%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and MOLN.SW has daily volatility of 9.08.Check MOLN.SW's competition here
MOR.SW vs MMTX.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, MMTX.SW has a market cap of 53.4M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while MMTX.SW trades at CHF 0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas MMTX.SW's P/E ratio is N/A. In terms of profitability, MOR.SW's ROE is -1.84%, compared to MMTX.SW's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and MMTX.SW has daily volatility of 13.98.Check MMTX.SW's competition here
MOR.SW vs RLF.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, RLF.SW has a market cap of 36.3M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while RLF.SW trades at CHF 2.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas RLF.SW's P/E ratio is -2.12. In terms of profitability, MOR.SW's ROE is -1.84%, compared to RLF.SW's ROE of -0.49%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and RLF.SW has daily volatility of 6.90.Check RLF.SW's competition here
MOR.SW vs ADXN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, ADXN.SW has a market cap of 6M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while ADXN.SW trades at CHF 0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas ADXN.SW's P/E ratio is -0.67. In terms of profitability, MOR.SW's ROE is -1.84%, compared to ADXN.SW's ROE of -0.78%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and ADXN.SW has daily volatility of 9.76.Check ADXN.SW's competition here
MOR.SW vs EVE.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, EVE.SW has a market cap of 6M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while EVE.SW trades at CHF 0.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas EVE.SW's P/E ratio is -6.92. In terms of profitability, MOR.SW's ROE is -1.84%, compared to EVE.SW's ROE of -0.13%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and EVE.SW has daily volatility of 8.98.Check EVE.SW's competition here
MOR.SW vs SPEX.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, SPEX.SW has a market cap of 3.9M. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while SPEX.SW trades at CHF 0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas SPEX.SW's P/E ratio is -0.15. In terms of profitability, MOR.SW's ROE is -1.84%, compared to SPEX.SW's ROE of N/A. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and SPEX.SW has daily volatility of 13.08.Check SPEX.SW's competition here
MOR.SW vs OBSN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, OBSN.SW has a market cap of 140.6K. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while OBSN.SW trades at CHF 0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas OBSN.SW's P/E ratio is -0.00. In terms of profitability, MOR.SW's ROE is -1.84%, compared to OBSN.SW's ROE of -1.46%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and OBSN.SW has daily volatility of 131.43.Check OBSN.SW's competition here
MOR.SW vs POLN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, POLN.SW has a market cap of 0. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while POLN.SW trades at CHF 1.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas POLN.SW's P/E ratio is -0.46. In terms of profitability, MOR.SW's ROE is -1.84%, compared to POLN.SW's ROE of -1.32%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and POLN.SW has daily volatility of 7.16.Check POLN.SW's competition here
MOR.SW vs SKIN.SW Comparison April 2026
MOR.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MOR.SW stands at 2.4B. In comparison, SKIN.SW has a market cap of 0. Regarding current trading prices, MOR.SW is priced at CHF 102.00, while SKIN.SW trades at CHF 35.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MOR.SW currently has a P/E ratio of -4.03, whereas SKIN.SW's P/E ratio is -28.13. In terms of profitability, MOR.SW's ROE is -1.84%, compared to SKIN.SW's ROE of -1.27%. Regarding short-term risk, Volatility data is not available for a full comparison. MOR.SW has daily volatility of N/A and SKIN.SW has daily volatility of 11.76.Check SKIN.SW's competition here